| Literature DB >> 30131945 |
Ankur Midha1, Katharina Janek2, Agathe Niewienda2, Petra Henklein3, Sebastian Guenther4,5, Diego O Serra6, Josephine Schlosser1, Regine Hengge6, Susanne Hartmann1.
Abstract
Ascariasis is a widespread soil-transmitted helminth infection caused by the intestinal roundworm Ascaris lumbricoides in humans, and the closely related Ascaris suum in pigs. Progress has been made in understanding interactions between helminths and host immune cells, but less is known concerning the interactions of parasitic nematodes and the host microbiota. As the host microbiota represents the direct environment for intestinal helminths and thus a considerable challenge, we studied nematode products, including excretory-secretory products (ESP) and body fluid (BF), of A. suum to determine their antimicrobial activities. Antimicrobial activities against gram-positive and gram-negative bacterial strains were assessed by the radial diffusion assay, while effects on biofilm formation were assessed using the crystal violet static biofilm and macrocolony assays. In addition, bacterial neutralizing activity was studied by an agglutination assay. ESP from different A. suum life stages (in vitro-hatched L3, lung-stage L3, L4, and adult) as well as BF from adult males were analyzed by mass spectrometry. Several proteins and peptides with known and predicted roles in nematode immune defense were detected in ESP and BF samples, including members of A. suum antibacterial factors (ASABF) and cecropin antimicrobial peptide families, glycosyl hydrolase enzymes such as lysozyme, as well as c-type lectin domain-containing proteins. Native, unconcentrated nematode products from intestine-dwelling L4-stage larvae and adults displayed broad-spectrum antibacterial activity. Additionally, adult A. suum ESP interfered with biofilm formation by Escherichia coli, and caused bacterial agglutination. These results indicate that A. suum uses a variety of factors with broad-spectrum antibacterial activity to affirm itself within its microbe-rich environment in the gut.Entities:
Keywords: antimicrobial peptides; ascariasis; biofilm; helminth; intestinal nematode; lectin; microbiota
Mesh:
Substances:
Year: 2018 PMID: 30131945 PMCID: PMC6090379 DOI: 10.3389/fcimb.2018.00271
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Ascaris suum excretory/secretory products and body fluid possess antimicrobial activity. Five microliter of nematode products were applied to agar plates with proliferating bacteria for 18 h at 37°C and growth inhibition zones measured in millimeters. Ascaris products tested include native excreted and secreted products (ESP) from adult worms kept in culture for 24 h, body fluid (BF) from adult males, native ESP from approximately 30,000 L3-stage larvae hatched in vitro/mL media, native ESP from approximately 100 L4-stage larvae/mL media, and a synthetic form of the A. suum antimicrobial peptide, cecropin P1. Larval (RPMI) and adult worm media (BSS) were included as controls. (A) Representative agar plate of a radial diffusion assay, with nematode products tested against E. coli. (B) Activity shown as diameter (mm) of inhibition zones on agar plates. Results are expressed as means ± standard deviations obtained from 2 to 3 independent experiments with multiple batches of A. suum products (L3 n = 3, L4 n = 2, adult ESP and body fluid n = 3). “−” represents no detected activity. “/” = not tested.
Figure 2Ascaris suum excretory/secretory products decrease biomass of submerged biofilms. Biofilm forming E. coli K-12 strains (A) AR3110 and (B) AR115 (a wcaE derivative of AR3110) were grown in 96-well cell culture plates in salt-free LB medium for 18 h at 37°C in the presence of adult A. suum excreted/secreted products (ESP) or adult worm media (BSS) as a control. Treatment doses were added as a percentage (v/v) of final culture volume (total = 200 μL per well). Results represented as the mean of three independent experiments ± SEM. Significance determined by 2-way ANOVA with Tukey's multiple comparison tests, *p < 0.05.
Figure 3Ascaris suum excretory/secretory products impair macrocolony biofilm formation. Five microliter of bacterial suspensions grown overnight were spotted on salt-free LB agar plates supplemented with Congo red, a dye that acs as an extracellular matrix indicator staining both pEtN-cellulose and curli fibers, as well as Coomassie brilliant blue and infused with either adult worm media (media control) or adult A. suum excreted/secreted products (ESP). Inoculated plates were then grown for up to 5 days at 28°C. Images shown here correspond to 5-days-old macrocolony biofilms of E. coli AR3110 and AR155 strains treated or untreated with A. suum ESP at two different concentrations.
Figure 4Ascaris suum excretory/secretory products cause bacterial agglutination. Bacterial agglutination in the presence of adult A. suum ESP and 10 mM CaCl2. Representative images of agglutination of E. coli IMT19224 with serial dilutions (1/2 factor) of A. suum ESP. Controls of agglutination include adult worm media (BSS) with and without CaCl2 as well as the C-type lectins wheat germ agglutinin (WGA) and concanavalin A (Con A). Bacteria visualized at 400X magnification.
Proteins and peptides with known and predicted antimicrobial activities detected in excreted/secreted products and body fluid of A. suum.
| C-type lectin domain-containing protein 160 | 41,886 | + | F1L7R9 |
| C-type lectin domain-containing protein 160 | 47,612 | + | F1L4K4 |
| C-type lectin domain-containing protein 160 | 43,174 | F1L8I9 | |
| C-type lectin protein 160 | 60,173 | − | F1L0R7 |
| 32 kDa beta-galactoside-binding lectin | 32,483 | − | F1L893 |
| 32 kDa beta-galactoside-binding lectin | 31,791 | − | F1LAD2 |
| GH family 25 lysozyme 2 | 24,644 | + | F1LE63 |
| GH family 25 lysozyme 2 | 21,687 | − | F1LEA7 |
| Cystatin | 13,961 | + | F1LHQ3 |
| ASABF-alpha | 9,843 | + | P90683 |
| ASABF-beta | 9,219 | + | Q8MMG8 |
| ASABF-epsilon | 7,037 | + | Q8IAC9 |
| Cecropin-P1 | 7,876 | + | P14661 |
| Cecropin-P2 | 9,760 | + | Q5H7N6 |
| Cecropin-P3 | 8,381 | + | Q5H7N5 |
| Cecropin-P4 | 8,424 | + | Q5H7N4 |
| Cecropin-P1 and/or Cecropin-P2 | 7,876/9,760 | + | P14661/Q5H7N6 |
| Cecropin-P3 | 8,381 | + | Q5H7N5 |
| Cecropin-P4 | 8,424 | + | Q5H7N4 |
| Cecropin P1 | 7,876 | + | P14661 |
| Cecropin-P2 | 9,760 | + | F1LBL1 |
| Cecropin-P3 | 8,381 | + | Q5H7N5 |
| Cecropin-P1 or Cecropin-P2 | 7,876 | + | P14661/Q5H7N6 |
| Cystatin | 13,961 | + | F1LHQ3 |
Extended version of table available in Supplementary Material.
Protein name and mass from Uniprot database (.
Identified proteins predicted to contain secretory signal peptide (+) or not (−) using SignalP.